Published in
Impact Journals, Oncotarget, 51(8), p. 89256-89268, 2017
DOI: 10.18632/oncotarget.19204
Links
Tools
A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy
Journal article published in 2015 by
Brent A. Williams,
Arjun Datt Law 
,
Bertrand Routy,
Neal denHollander,
Vikas Gupta ,
Xing-Hua Wang,
Amélie Chaboureau,
Sowmya Viswanathan ,
Armand Keating
,
Bertrand Routy,
Neal denHollander,
Vikas Gupta ,
Xing-Hua Wang,
Amélie Chaboureau,
Sowmya Viswanathan ,
Armand Keating
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 